Real-life experience of secondary prophylaxis with DOACs in splanchnic venous thrombosis during COVID-19 pandemic

Ann Hematol. 2023 Jun;102(6):1607-1608. doi: 10.1007/s00277-023-05184-8. Epub 2023 Mar 25.

Authors

Luca Guarnera¹, Elisa Buzzatti¹, Fabrizio Bonanni¹, Giovangiacinto Paterno¹, Antonella Riccitelli¹, Vittorio Forte¹, Adriano Venditti², Maria Ilaria Del Principe¹

Affiliations

¹ Hematology, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
² Hematology, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy. [email protected].

No abstract available

Publication types

Letter

MeSH terms

Anticoagulants / therapeutic use
COVID-19*
Humans
Pandemics
Secondary Prevention
Venous Thromboembolism*
Venous Thrombosis* / drug therapy
Venous Thrombosis* / etiology
Venous Thrombosis* / prevention & control

Substances

Anticoagulants